These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 12121930

  • 1. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.
    Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF.
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2540-5. PubMed ID: 12121930
    [Abstract] [Full Text] [Related]

  • 2. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
    Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ.
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1089-92. PubMed ID: 10722520
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
    Sanchez GV, Baird AM, Karlowsky JA, Master RN, Bordon JM.
    J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
    [Abstract] [Full Text] [Related]

  • 6. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
    Arredondo-García JL, Amábile-Cuevas CF.
    J Infect Dev Ctries; 2008 Oct 01; 2(5):350-3. PubMed ID: 19745501
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
    Karlowsky JA, Hoban DJ, Decorby MR, Laing NM, Zhanel GG.
    Antimicrob Agents Chemother; 2006 Jun 01; 50(6):2251-4. PubMed ID: 16723598
    [Abstract] [Full Text] [Related]

  • 10. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
    Valentine-King M, Zoorob R, Grigoryan L, Trautner B.
    Ann Fam Med; 2022 Apr 01; 20(20 Suppl 1):. PubMed ID: 36944052
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.
    Clin Infect Dis; 2003 Jan 15; 36(2):183-7. PubMed ID: 12522750
    [Abstract] [Full Text] [Related]

  • 12. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
    Delisle G, Quach C, Domingo MC, Boudreault AA, Gourdeau M, Bernatchez H, Lavallée C.
    J Antimicrob Chemother; 2016 Dec 15; 71(12):3562-3567. PubMed ID: 27494927
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients.
    Bruyndonckx R, Latour K, Atud GA, Dubovy P, Jaspers S, Hens N, Catry B, Goossens H, Coenen S.
    J Antimicrob Chemother; 2019 Nov 01; 74(11):3264-3267. PubMed ID: 31377782
    [Abstract] [Full Text] [Related]

  • 15. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
    Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, McDermott T, Murphy P, Grainger R, Fennell JP, Thornhill JA.
    BJU Int; 2012 Apr 01; 109(8):1198-206. PubMed ID: 21883861
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD, MacDonald N, Fuite L, Chan F, Stephens D.
    CMAJ; 1999 May 18; 160(10):1436-40. PubMed ID: 10352632
    [Abstract] [Full Text] [Related]

  • 17. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
    Rock W, Colodner R, Chazan B, Elias M, Raz R.
    Isr Med Assoc J; 2007 Nov 18; 9(11):803-5. PubMed ID: 18085038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.